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Background: Insufficient incorporation of heme is considered a central impeding cause in the recombinant
production of active heme proteins. Currently, two approaches are commonly taken to overcome this bottleneck;
metabolic engineering of the heme biosynthesis pathway in the host organism to enhance intracellular heme
production, and supplementation of the growth medium with the desired cofactor or precursors thereof to allow
saturation of recombinantly produced apo-forms of the target protein. In this study, we investigated the effect of
both, pathway engineering and medium supplementation, to optimize the recombinant production of the heme
protein horseradish peroxidase in the yeast Pichia pastoris.
Results: In contrast to studies with other hosts, co-overexpression of genes of the endogenous heme biosynthesis
pathway did not improve the recombinant production of active heme protein. However, medium supplementation
with hemin proved to be an efficient strategy to increase the yield of active enzyme, whereas supplementation with
the commonly used precursor 5-aminolevulinic acid did not affect target protein yield.
Conclusions: The yield of active recombinant heme peroxidase from P. pastoris can be easily enhanced by
supplementation of the cultivation medium with hemin. Thereby, secreted apo-species of the target protein
are effectively saturated with cofactor, maximizing the yield of target enzyme activity.
Keywords: Pichia pastoris, Recombinant protein production, Plant peroxidase, Horseradish peroxidase, Metabolic
engineering, Cofactor, Heme, Heme biosynthesis, Apo-proteinBackground
The methylotrophic yeast Pichia pastoris is a valuable
host for the recombinant production of complex proteins.
A considerable number of these proteins requires cofactors,
amongst others heme, to form active biocatalysts. Heme
biosynthesis (Figure 1) is tightly regulated and highly
conserved throughout evolution [1-3].
To deepen our understanding on pathway regulation
and improve cofactor availability for recombinant heme
proteins, metabolic engineering of the heme biosynthesis
pathway has been performed in Aspergillus niger [4,5],
Escherichia coli [6] and Saccharomyces cerevisiae [7-9].
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unless otherwise stated.pathway, distinct differences were found among the differ-
ent species. In E. coli, formation of 5-aminolevulinic acid
(ALA) by the HEM1-encoded ALA synthase was de-
scribed as rate-limiting step [10], whereas in S. cerevisiae
the HEM2- and HEM3-encoded porphobilinogen syn-
thase and deaminase, respectively, were described as rate-
limiting [7]. Based thereon, overexpression of HEM3 alone
or in combination with HEM2 and HEM12 was described
to be a valuable strategy to augment the production of
recombinant heme proteins in S. cerevisiae [9,11]. Despite
these promising results, there are some potential pitfalls
connected to metabolic pathway engineering, such as the
additional metabolic burden upon overexpression of mul-
tiple genes as well as an accumulation of free intracellular
porphyrin intermediates which can lead to the formation
of reactive oxygen species [12]. Thus, medium supple-
mentation with iron, heme precursors or hemin (the fer-
ric chloride species of heme) was assessed as alternativeThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Scheme of the heme biosynthesis pathway. ALAS, 5-aminolevulinic acid synthase; PBGS, porphobilinogen synthase; PBGD,
porphobilinogen deaminase; UROS, uroporphyrinogen III synthase; UROD, uroporphyrinogen III decarboxylase; COPROX, coproporphyrinogen III
oxidase; PROTOX, protoporphyrinogen IX oxidase; FC, ferrochelatase.
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heme proteins [13-17].
In this study, we aimed at optimizing heme availability
and thus boost the amount of recombinant active heme
protein, namely horseradish peroxidase (HRP), in the
yeast P. pastoris by evaluating pathway engineering and
medium supplementation. In a systematic approach, we
co-overexpressed HRP with genes of the endogenous
heme biosynthesis pathway of P. pastoris, and assessed
the effect of medium supplementation with iron, ALA
and hemin on the yield of target enzyme activity.
Results and discussion
Heme biosynthesis pathway in Pichia pastoris
The heme biosynthesis pathway of several organisms has
been described before and was found to be highly con-
served [1-3]. Based on the HEM gene sequences from
S. cerevisiae, we identified the corresponding homologsTable 1 In silico identification of HEM homologs in P. pastoris
S. cerevisiae P. pastoris
Gene annotation Gene annotation Chromosome
HEM1 HEM1 II
HEM2 HEM2 IV
HEM3 HEM3 I
HEM4 HEM4 II
HEM12 n/a III
HEM13 HEM13 III
HEM14 n/a IV
HEM15 n/a III
Genes HEM12, HEM14 and HEM15 were not annotated (n/a) for P. pastoris CBS 7435
groups (COG; [19]) annotations and identities of the encoded amino acid sequencein the partially annotated genome of P. pastoris [18]
in silico (Table 1). Sanger sequencing confirmed the cor-
rect nucleotide sequences of HEM1, HEM2, HEM3, HEM4,
HEM12, HEM13 and HEM14. For HEM15, nucleotide 918
was G in the GenBank database entries of the published
genomes of P. pastoris strains CBS 7435 and GS155, but
T in the Sanger-sequenced CBS 7435 P. pastoris strain
used in the present study (Additional file 1). However, this
single nucleotide polymorphism only resulted in a silent
mutation and did not alter the amino acid sequence of the
encoded protoheme ferro-lyase.
Co-overexpression of HEM genes in microscale
cultivations
In a recent study it was shown that metabolic engineering
of the heme biosynthesis pathway allowed higher yields of
active recombinant heme protein in S. cerevisiae [11].
Thus, we co-overexpressed either of the eight involvedSequence
identity [%]COG annotation
5-aminolevulinate synthase 67.7
delta-aminolevulinic acid dehydratase 75.3
porphobilinogen deaminase 54.0
uroporphyrinogen-III synthase 42.3
uroporphyrinogen decarboxylase 73.2
coproporphyrinogen III oxidase 65.5
protoporphyrinogen oxidase 33.7
protoheme ferro-lyase (ferrochelatase) 61.2
. Their chromosomal position in the genome, eukaryotic cluster of orthologous
s from S. cerevisiae and P. pastoris are shown.
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moter PGAP [20] in a P. pastoris strain recombinantly pro-
ducing the heme protein HRP. The screenings revealed
trends of co-overexpressed HEM1 and HEM3 to be poten-
tially beneficial for the production of active HRP (Figure 2).
Surprisingly, there also seemed to be a negative trend upon
co-overexpression of HEM4. We hypothesize, that HEM4
co-overexpression might have led to the accumulation
of a cytotoxic intermediate, which increased intracellular
stress and ultimately caused a disadvantageous production
environment for HRP under the tested conditions. At this
point, we did not follow up on the effects of HEM4 co-
overexpression. Since co-overexpression of eGFP as nega-
tive control did not affect HRP productivity, the observed
activity-enhancing trends seen for HEM1 and HEM3 were
considered a consequence of the co-overexpressed HEM
gene, although the standard deviation in these experi-
ments was high. The high standard deviations in this
screening (Figure 2) were caused by the transformant-to-
transformant variation typically observed for P. pastoris
[21]. Even the transformation of a single gene results in
transformants showing different expression strengths. The
majority of the transformants shaping the landscape be-
haved similar but a few transformants showed either no
expression or elevated levels, leading to high standard
deviations. Supplementation of the cultivation medium
with 1 mM FeSO4 to alleviate a potential iron limitation
gave comparable results to non-supplemented mediumFigure 2 Co-overexpressions of HEM genes with HRP. HRP overexpress
regulated by PGAP. Bars are average values of HRP production landscapes fro
Error bars are standard deviations from all measured clones of a landscape. Aand did not affect the observed trends upon HEM gene
co-overexpression (data not shown).
In addition to strong constitutive co-overexpression of
either HEM1 or HEM3 from PGAP, we also tested co-
overexpression of these two genes from either PAOX1 or
PCAT1. Both promoters are strongly methanol-inducible,
however PCAT1 is already active in the absence of glu-
cose or glycerol and then even further induced by addition
of methanol, thereby allowing HEM co-overexpression
already prior to, but also during HRP production [Vogl
et al., manuscript in preparation]. In order to indirectly
assess the general functionality and applicability of the
employed co-overexpression construct, we measured fluor-
escence of the eGFP co-overexpression control transfor-
mants and found this co-overexpression partner to be
successfully produced (Additional file 2). Thus, we consid-
ered the endogenous HEM co-overexpression partners to
be co-overexpressed in a comparable fashion. Ultimately,
PAOX1-regulated co-overexpressions of HEM1 and HEM3
with HRP were found most promising (Additional file 3)
and the best performing strains were used for further
characterizations.
Since the data from microscale cultivations indicated merely
trends for potential beneficial effects of co-overexpressed
HEM1 or HEM3, we aimed at obtaining more reliable
data from controlled cultivations of the best performing
strains in bioreactors. Prior to bioreactor cultivations, the
strain producing HRP alone (hereafter called benchmarkion was regulated by PAOX1, co-overexpressions of eGFP and HEM were
m microscale cultivations using 1 mM FeSO4-supplemented medium.
verage activity from strains producing HRP alone was set to 100%.
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strains (hereafter called HEM1 and HEM3 strains) were
characterized by quantitative real-time PCR as strains with
single copy integration of the HRP gene. Since these
strains contained the same HRP gene dosage, genomic re-
arrangement of HRP gene copy number upon transform-
ation of a HEM co-overexpression construct was excluded
and the strains were regarded comparable in terms of tar-
get gene dosage.
Co-overexpression of HEM genes in bioreactor
cultivations
For physiological strain characterisation of the three yeast
strains we employed a previously reported strategy of dy-
namic batch cultivations with methanol pulses [22-25].
The corresponding off-gas signals, specific uptake rates
and yields are shown in Additional file 4. Physiological
strain characteristic parameters of the three strains are
summarized in Table 2. As shown in Table 2, C-balances
for all cultivations closed to 1.0 indicating solid data qual-
ity. Apparently, the yeast strains were physiologically not
impaired by co-overexpression of either HEM1 or HEM3
since adaptation time to methanol, yields and specific
substrate uptake rates were comparable. However, co-
overexpressing these genes did not boost the production
of active HRP either. Whereas the benchmark and the
HEM1 strain showed comparable production titres, the
HEM3 strain even showed a 50% lower specific and volu-
metric productivity than the benchmark strain. Taken to-
gether, it turned out that the trends seen in microscale
data could not be seen in the bioreactor. A possible ex-
planation for these diverging findings could be found in
the considerably different cultivation conditions. Micro-
scale cultivations may challenge cell growth and product-
ivity by phases of O2 shortage or starvation, whereas a
bioreactor provides optimal cultivation conditions.
Considering the complex and so far poorly understood
regulation of heme biosynthesis, a multitude of single or
combined factors may have either positive or negative
effects on this pathway. Thus, additional studies will be
required to unravel the regulation of heme biosynthesis, in
order to allow non-speculative conclusions. Since our se-
lection of HEM co-overexpression partners was based on
trends from microscale cultivations, we cannot exclude,Table 2 Strain characteristic physiological parameters determ
Strain Δtimeadapt
[h]
YX/MeOH
[C-mol/C-mol]
YCO2/MeOH
[C-mol/C-mo
Benchmark 8.2 0.02 1.00
HEM1 8.2 0.04 0.94
HEM3 7.9 0.03 0.93
Δtimeadapt, time for adaptation of the culture to methanol; YX/MeOH, YCO2/MeOH, yield
YX/MeOH and YCO2/MeOH which ideally should result in 1.0; qMeOH, average specif
HRP productivity; rp, volumetric HRP productivity calculated from the point of ithat either of the remaining six HEM genes or combina-
tions thereof might yield more beneficial results than co-
overexpressed HEM1 or HEM3 in bioreactor cultivations.
Ultimately, in contrast to analogous studies in S. cerevisiae
[9,11], metabolic pathway engineering in P. pastoris did
not prove to be a useful strategy to allow higher titres of
recombinant active heme protein, suggesting distinct dif-
ferences of this pathway between the two yeasts. However,
co-overexpression of two or more HEM genes from a li-
brary of promoters of varying strengths might still en-
hance endogenous heme biosynthesis in P. pastoris and
will be assessed in future studies.
Medium supplementation
Medium supplementation in microscale cultivations
We tested ALA, FeSO4 and hemin as medium supple-
ments in microscale cultivations of the benchmark strain.
Supplementation with ALA at an excess concentration of
1 mM, as reported in literature [22,26,27], did not result
in measurably more active product. However, addition of
1 mM FeSO4 boosted the amount of active HRP up to
7-fold (Figure 3), hinting at a potential shortage of iron in
heme biosynthesis. Upon supplementation of the minimal
medium with different concentrations of hemin, we even
measured 18-fold increased HRP activity compared to
non-supplemented conditions. We also investigated the
effect in case both, FeSO4 and hemin, were supplemented
concomitantly and observed that the beneficial effect of
FeSO4 became less pronounced with increasing concen-
trations of hemin (Figure 3). Apparently, as all apo-HRP
was readily saturated with cofactor at a hemin concentra-
tion of 10 μM, additional excess of iron did not improve
HRP activities any further and the cofactor bottleneck was
opened up.
ALA supplementation in the bioreactor
We performed a comparative cultivation experiment in
the bioreactor to confirm the results obtained in micro-
scale cultivations that the commonly used supplement
ALA [22,26,27] does not affect the production of a recom-
binant active heme protein in P. pastoris. We cultivated
the benchmark strain in parallel dynamic batch cultiva-
tions with and without the presence of 1 mM ALA. Table 3
shows that both, strain physiology and productivity, wereined for the benchmark, HEM1 and HEM3 strain
l]
C-balance qMeOH
[mmol/g/h]
qp
[U/g/h]
rp
[U/L/h]
1.02 0.75 1.11 37.5
0.98 0.69 1.10 35.9
0.96 0.70 0.49 17.1
s of biomass or CO2 per C-mol of substrate methanol; C-balance, sum of
ic uptake rate of methanol during consecutive methanol pulses; qp, specific
nduction until the end of cultivation.
Figure 3 Effect of medium supplementation with FeSO4 and hemin on HRP activity in microscale cultivations. Volumetric HRP activity
from minimal medium without supplementation was set to 100%. Bars are average values ± SD from independent triplicate cultivations. Light
gray, no FeSO4; dark gray, 1 mM FeSO4.
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active HRP was the same for both conditions, we con-
cluded that ALA was not beneficial for the activation of
the produced apo-HRP. This observation is different from
what was described previously by Morawski et al., where a
32% increase in HRP activity was measured in the cul-
ture supernatant after supplementation with ALA, trace
elements and thiamine [17]. Thus, we speculate that
the activation effect observed by Morawski et al. was
rather caused by the addition of the iron-containing
trace element solution than by ALA. Furthermore, our
results conclusively showed that the intracellular pro-
duction of ALA in the heme biosynthesis pathway of
P. pastoris was not the rate limiting step in contrast to
E. coli [10], which is also in agreement with the study
of Arrese et al. [28].
Optimization of hemin supplementation in the bioreactor
Based on the results obtained in microscale cultivations,
we supplemented the cultivation broth of three parallel
dynamic batch cultivations of the benchmark strain with
0.1, 1.0 or 10.0 μM hemin. As shown in Table 4, adapta-
tion time, yields and uptake rates of the benchmarkTable 3 Strain specific physiological parameters of the bench
ALA
[1 mM]
Δtimeadapt
[h]
YX/MeOH
[C-mol/C-mol]
YCO2/MeOH
[C-mol/C-mol]
+ 8.1 0.03 0.95
- 8.2 0.04 0.94
Δtimeadapt, time for adaptation of the culture to methanol; YX/MeOH, YCO2/MeOH, yield
YX/MeOH and YCO2/MeOH which ideally should result in 1.0; qMeOH, average specif
HRP productivity; rp, volumetric HRP productivity calculated from the point of istrain were not affected by the presence of hemin. In
terms of productivity, both the specific and the volumetric
productivity were doubled at a concentration of 10.0 μM
hemin. Since the total extracellular protein content was
comparable in all three cultivations, we concluded that
not the productivity of the yeast was altered, but rather
that the produced apo-protein was activated posttransla-
tionally by hemin in the cultivation broth. Based on
our previous experiences with this expression system
[22,23,29,30], we estimated the amount of HRP in the
cultivation broth to be < 3 μM. Thus, we concluded that
an excess hemin concentration is required to effectively
saturate secreted apo-HRP (Table 4).
Activation studies with hemin
To prove our hypothesis of a posttranslational conversion
of apo-HRP to holo-HRP by hemin, we incubated cell-
free, sterile-filtered supernatant from a non-supplemented
benchmark cultivation with different concentrations of
hemin and analyzed activity over time. As shown in
Table 5, already after 5 min of incubation a concentration
dependent activation was observed and after 72 h of incu-
bation the initial activity was even doubled. Based thereon,mark strain with and without ALA supplementation
C-balance qMeOH
[mmol/g/h]
qp
[U/g/h]
rp
[U/L/h]
0.98 0.73 1.08 36.7
0.98 0.76 1.09 37.2
s of biomass or CO2 per C-mol of substrate methanol; C-balance, sum of
ic uptake rate of methanol during consecutive methanol pulses; qp, specific
nduction until the end of cultivation.
Table 4 Strain characteristic physiological parameters determined for the benchmark strain cultivated in
hemin-supplemented media
Hemin
[μM]
Δtimeadapt
[h]
YX/MeOH
[C-mol/C-mol]
YCO2/MeOH
[C-mol/C-mol]
C-balance qMeOH
[mmol/g/h]
qp
[U/g/h]
rp
[U/L/h]
0.1 6.5 0.04 0.89 0.93 0.69 1.10 34.3
1.0 6.4 0.04 0.93 0.97 0.71 1.26 36.8
10.0 6.5 0.03 0.89 0.96 0.70 2.35 73.2
Δtimeadapt, time for adaptation of the culture to methanol; YX/MeOH, YCO2/MeOH, yields of biomass or CO2 per C-mol of substrate methanol; C-balance, sum of YX/MeOH
and YCO2/MeOH which ideally should result in 1.0; qMeOH, average specific uptake rate of methanol during consecutive methanol pulses; qp, specific HRP productivity;
rp, volumetric HRP productivity.
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allow effective apo-protein activation.
Conclusions
In this study we present a systematic approach to optimize
heme availability and thus boost the amount of active
heme protein produced in the yeast P. pastoris by evaluat-
ing metabolic pathway engineering and medium supple-
mentation. The results can be summarized as:
 The heme biosynthesis pathway of P. pastoris was
analyzed and corresponding genes were identified
and annotated in silico.
 In contrast to previous studies, overexpression of single
HEM genes did not result in enhanced activity or
higher yield of the model heme protein HRP in
bioreactor cultivations of recombinant P. pastoris
strains. However, combinations of HEM genes co-
overexpressed from a library of differently regulated
promoters might still enhance endogenous heme bio-
synthesis of P. pastoris.
 Medium supplementation with the traditionally used
and pricy heme precursor ALA did not increase the
yield of active product and can be omitted in future
cultivations. FeSO4 and hemin on the other hand
turned out to be useful medium supplements to
increase the yield of active heme protein.
 Hemin was identified as the most effective supplement.
It activated the secreted model heme protein
posttranslationally in the cultivation broth and should
be added in moderate excess to effectively saturate
secreted apo-species of the target protein.Table 5 Posttranslational activation of apo-HRP with hemin
Hemin
[μM]
Specific activity [U/mg]
after 5 min of incubation
Specific activity [U/mg]
after 72 h of incubation
- 34.8 35.3
1.0 42.4 67.0
5.0 46.8 75.4
10.0 51.8 77.8
Cell-free cultivation supernatant was incubated with the indicated concentrations
of hemin and volumetric HRP activity was measured after 5 min and 72 h.The results shown in this study present a guideline for
the successful recombinant production of active heme pro-
tein in the yeast P. pastoris and offer an easy-to-do solution
to maximize the ratio of holo- over apo-protein resulting in
a considerable increase of active target protein.
Methods
Chemicals
2,2′-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) dia-
mmonium salt (ABTS), D(+)-biotin and hemin were pur-
chased from Sigma-Aldrich (Austria). Difco™ yeast nitrogen
base (YNB) w/o amino acids, Bacto™ tryptone and Bacto™
yeast extract were obtained from Becton Dickinson (Austria).
Zeocin™ was obtained from InvivoGen (France). Other
chemicals were obtained from Carl Roth (Germany).
Pichia pastoris strains
All strains in this study were based on the P. pastoris
wildtype strain CBS 7435 (identical to NRRL Y-11430
and ATCC 76273). The MutS phenotype has been found
previously to be superior over the Mut+ phenotype for
recombinant HRP production in terms of volumetric
productivity and production efficiency [24]. Hence, an
aox1 deletion strain (PpMutS) was used as starting strain
[31]. Homologs of the HEM genes of S. cerevisiae were
identified by BLAST searches [32] in the published gen-
ome sequence of P. pastoris CBS 7435 [18] and the se-
quences were verified by Sanger sequencing (Microsynth,
Austria). Sequence identities of the HEM gene products
from S. cerevisiae and P. pastoris were determined on the
LALIGN server.
The HRP expression construct was based on the pPpT4_
Alpha_S vector [31] where HRP C1A expression was under
control of the promoter of the AOX1 gene (PAOX1).
Transformants were identified by Zeocin™ resistance. The
S. cerevisiae MATα prepro signal peptide facilitated HRP
secretion. All HEM co-overexpression constructs were
based on the plasmid pPpKan_S [32], harboring a kana-
mycin resistance gene for selection and the strongly
methanol-inducible PAOX1 for gene expression. Also, the
promoters PGAP and PCAT1 [Vogl et al., manuscript in
preparation] were tested for co-overexpression. Trans-
formation of the HRP expression cassette to PpMutS and
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HRP production strain (called benchmark strain) was per-
formed as described previously [24]. All eight HEM genes
of the heme biosynthesis pathway were co-overexpressed
separately and their influence on HRP production was
studied by cultivation of approximately 80 transformants
per co-overexpression construct in 96-deep well plates
(DWP). As negative co-overexpression control, eGFP was
co-overexpressed with HRP. The copy number of the HRP
gene in selected strains was determined by quantitative
real-time PCR according to a previous protocol [33] and as
described recently [24].
Microscale cultivations in 96-deep well plates
Microscale cultivations in 96-DWPs were performed simi-
lar to [34]: Strains were grown in 250 μL BMD1% (11 g/L
alpha-D(+)-glucose monohydrate, 13.4 g/L YNB, 0.4 mg/L
D(+)-biotin, 0.1 M potassium phosphate buffer, pH 6.0) at
28°C, 320 rpm, 80% humidity. After approximately 60 h,
an induction pulse of 250 μL BMM2 (1% (v/v) methanol,
13.4 g/L YNB, 0.4 mg/L D(+)-biotin, 0.1 M potassium
phosphate buffer, pH 6.0) was added, followed by three
pulses of 50 μL BMM10 (5% (v/v) methanol, 13.4 g/L
YNB, 0.4 mg/L D(+)-biotin, 0.1 M potassium phosphate
buffer, pH 6.0) per well 12, 24 and 36 h after the first pulse.
HRP activity was determined by mixing 15 μL supernatant
with 140 μL assay solution (1 mM ABTS, 0.9 mM H2O2,
50 mM sodium acetate, pH 4.5) in a microtiter plate
and following the increase in absorbance at 405 nm on a
Spectramax Plus 384 platereader (MolecularDevices,
Germany) at room temperature. Medium supplemen-
tation studies were performed by additions of ALA,
FeSO4 and hemin to BMD1% from a 100 mM ALA
stock, a 100 mM FeSO4 stock and a 500 μM hemin
stock (in 10 mM KOH), respectively.
Bioreactor cultivations
Preculture
Precultures were grown in YNB medium (0.1 M potassium
phosphate buffer, pH 6.0; 3.4 g/L YNB w/o amino acids
and ammonium sulfate; 10 g/L (NH4)2SO4; 400 mg/L
biotin; 20 g/L glucose) in 1 L shake flasks at 30°C and
230 rpm for 24 h.
Dynamic batch cultivations
For dynamic batch cultivations, 1.8 L of double concen-
trated basal salt medium (BSM; 26.7 mL/L 85% phosphoric
acid; 1.17 g/L CaSO4 · 2H2O; 18.2 g/L K2SO4; 14.9 g/L
MgSO4 · 7H2O; 4.13 g/L KOH; 0.3 mL/L Antifoam
Struktol J650; 60 g/L glycerol) were sterilized in 3 L
bioreactor vessels (DR03F; DASGIP, Switzerland). After
sterilization, 4.35 mL/L trace element solution (PTM1;
6.0 g/L CuSO4 · 5H2O; 0.08 g/L NaI; 3.0 g/L MnSO4 ·
H2O; 0.2 g/L Na2MoO4 · 2H2O; 0.02 g/L H3BO3; 0.5 g/LCoCl2; 20.0 g/L ZnCl2; 65.0 g/L FeSO4 · 7H2O; 0.2 g/L
biotin; 5 mL/L H2SO4) were added and pH was set to
5.0 with concentrated ammonia solution. The precultures
were transferred aseptically to the respective vessel (the in-
oculation volume was 10%) and a batch phase on glycerol
was carried out at 30°C with the stirrer fixed at 900 rpm.
Aeration with compressed dry air was set to 1 vvm.
Dissolved oxygen (dO2) was measured with a sterilizable
VisiFerm DO 225 probe (Hamilton, Switzerland) and con-
trolled to be higher than 20%. The pH was measured with
a sterilizable electrode (Mettler Toledo, Switzerland) and
maintained constant at pH 5.0. Reactor weight was
continuously recorded by a precision balance (Sartorius,
Germany). Following complete glycerol consumption as
indicated by an increase in the offgas signal, temperature
was lowered to 25°C and an adaptation pulse of 0.5% (v/v)
methanol (containing 4.35 mL/L PTM1) was added. After
adaptation, 1.0% (v/v) methanol was pulsed repeatedly (for
an example see Additional file 4). Before and after each
pulse samples were taken and analyzed for OD600, dry cell
weight, HRP activity, extracellular protein content and
methanol concentration.
Analysis of growth and expression parameters
Dry cell weight (DCW) was determined by centrifugation of
5 mL fermentation broth (4500 rpm, 10 min, 4°C), washing
the pellet with 5 mL water and subsequent drying to a con-
stant weight at 105°C. HRP activity in the cell-free super-
natant was determined using a previously described assay
[23] in a CuBiAn-XC enzymatic robot (OptoCell, Germany).
Protein concentration was determined using a Bradford pro-
tein assay kit (Thermo Scientific, USA). All growth and pro-
tein expression parameters were determined in duplicates.
Analysis of substrate concentration
Methanol concentration in the cell-free supernatant was
determined by HPLC as described previously [22]. Glycerol
concentration was measured from cell-free samples in the
CuBiAn-XC enzymatic robot. The device was calibrated
with water-diluted glycerol standards ranging from 0 to
0.25 g/L. Samples with higher glycerol concentrations
were automatically diluted by the system.
Calculation of strain physiological characteristics
Physiologically relevant parameters for characterization
of the different yeast strains cultivated at different con-
ditions and for quantification of the bioprocess were:
Carbon dioxide evolution rate (CER; mmol/L/h), bio-
mass yield (YX/MeOH; C-mol/C-mol), carbon dioxide yield
(YCO2/MeOH; C-mol/C-mol), C-balance, specific methanol
uptake rate (qMeOH; mmol/g/h), specific productivity
(qp; U/g/h), volumetric productivity (rp; U/L/h), specific
activity (U/mg). All details on the calculation of these pa-
rameters have been published previously [34].
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Additional file 1: Pichia pastoris CBS 7435 HEM open reading
frames. The single nucleotide polymorphism of HEM15, T918, is marked
in grey.
Additional file 2: Co-overexpression of eGFP from PAOX1. The
principial applicability of the employed co-overexpression construct
is demonstrated indirectly by eGFP fluorescence of the strains
co-overexpressing HRP and eGFP. The first two bars represent the
starting strain, PpMutS, and the benchmark strain as controls. Fluorescence
was determined at ex/em 488/507 nm, and normalized to the OD600 to
account for potential growth differences.
Additional file 3: Co-overexpressions of HRP with either HEM1 or
HEM3 from either PAOX1 or PCAT1. 1, co-overexpression of HEM1 or
HEM3 from PAOX1; 2, co-overexpression of HEM1 or HEM3 from PCAT1.
White bars, eGFP co-overexpression control; black bars, HEM1 co-
overexpression; gray bars, HEM3 co-overexpression. The benchmark strain
was included in all cultivations and set to 100% as reference (first bars).
Additional file 4: Batch cultivations of three recombinant P. pastoris
strains. 1, benchmark strain; 2, HEM1 strain; 3, HEM3 strain; a/c/e, CER
signal (solid line) and specific methanol uptake rate (open circles); b/d/f,
carbon dioxide yields (YCO2/S; grey squares) and biomass yields (YX/S;
black circles).
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